Clinical trial
A Phase I Study of Temsirolimus in Combination With Metformin in Advanced Solid Tumours
NCT00659568 is registered in ClinicalTrials.gov with London Health Sciences Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Temsirolimus in Combination With Metformin in Advanced Solid Tumours
- Lead sponsor
- London Health Sciences Centre
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- August 31, 2010
- Enrollment
- 28 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, endometrial cancer, kidney cancer, lung cancer, lymphoma, unspecified adult solid tumor, protocol specific